Understanding how a virus can persist and potentially cause cancer

Mechanism For Merkel Cell Polyomavirus Persistence

NIH-funded research University of Pittsburgh at Pittsburgh · NIH-11009996

This study is looking into how the Merkel cell polyomavirus can stick around in the body and possibly cause cancer, helping us understand how it hides from the immune system and what that means for people dealing with chronic viral infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh NIH-funded
Lab location1 site (Pittsburgh, United States)
Project IDNIH-11009996 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which Merkel cell polyomavirus (MCPyV) can persist in the body and lead to cancer. The study focuses on how the virus controls its replication and achieves latency, which allows it to evade the immune system. Using advanced technologies, researchers will analyze the interactions of viral proteins with the virus's genetic material to understand how these processes work at a molecular level. This could provide insights into chronic viral infections and their link to cancer development.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with chronic infections related to MCPyV or those at risk for Merkel cell carcinoma.

Not a fit: Patients who do not have any history of viral infections or cancers associated with MCPyV may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating cancers associated with chronic viral infections.

How similar studies have performed: Previous research has shown success in understanding latency mechanisms in other viruses, but this specific approach to MCPyV is relatively novel.

Where this research is happening

Pittsburgh, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.